![]() His experience at Horizon and his deep financial knowledge will be essential in continuing to drive our long-term strategy.” Additionally, he has been a leader in many of our major strategic efforts, including the Viela Bio acquisition. Walbert continued, “Aaron has been deeply involved in key aspects of our business during the last five years, including leading our capital markets activities. I would like to thank him for his leadership as well as his dedication and commitment to Horizon’s mission.” “He has built a strong finance team during his tenure and has been a valued partner to me and Horizon’s board of directors. “Paul has served as Horizon’s CFO since 2014 and has been critical in guiding and driving our growth,” said Tim Walbert, chairman, president and chief executive officer, Horizon. ![]() Aaron Cox, who was named executive vice president, finance, will succeed Mr. No cash balance or cash flow is included in the calculation.DUBLIN-( BUSINESS WIRE)-Horizon Therapeutics plc (Nasdaq: HZNP) today announced Paul Hoelscher, executive vice president, chief financial officer, will retire effective May 16, 2022, and continue as an advisor to the Company through May 2023. Please note all regulatory considerations regarding the presentation of fees must be taken into account. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Actual performance may differ significantly from backtested performance. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Backtested performance is developed with the benefit of hindsight and has inherent limitations. This information is provided for illustrative purposes only. No representations and warranties are made as to the reasonableness of the assumptions. Certain assumptions have been made for modeling purposes and are unlikely to be realized. Changes in these assumptions may have a material impact on the backtested returns presented. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. ![]() The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. ![]() Backtested performance is not an indicator of future actual results. Disclaimer: The TipRanks Smart Score performance is based on backtested results. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |